GlassScriptPhysician profile
Corey Valentine
NPI 1952612418
$375.95
in general payments reported to CMS, 2019-2025
8 companies · $24.67 in 2025
The $24.67 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2021: $57.77 · 2023: $78.24 · 2024: $105 · 2025: $24.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $208.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $78.45 | 2019-2023 | Physio-Stim |
| Organogenesis INC. | $73.38 | 2019-2023 | Puraply |
| Kerecis Limited | $71.56 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Paragon 28, INC. | $58.54 | 2024 | Portfolio |
| Medtronic, INC. | $38.81 | 2023 | Intellis Adaptivestim |
| Stryker Corporation | $29.33 | 2021 | |
| Smith+Nephew, INC. | $13.25 | 2021 | |
| Misonix INC | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Valentine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.